Cart
sales@molnova.com
HIV-gp120- Fragment (308-331)
CAS No. 115416-08-5
HIV-gp120- Fragment (308-331)( ——— )
Catalog No. M41282 CAS No. 115416-08-5
HIV gp120 308-331 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHIV-gp120- Fragment (308-331)
-
NoteResearch use only, not for human use.
-
Brief DescriptionHIV gp120 308-331 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody.
-
DescriptionHIV gp120 308-331 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number115416-08-5
-
Formula Weight2640.11
-
Molecular FormulaC114H199N41O31
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Justiz-Vaillant A, et al., In vivo administration of anti-HIV hyper-immune eggs induces anti-anti-idiotypic antibodies against HIV gp120 peptides (fragments 308-331 and 421-438) and against HIV gp41 peptide (fragment 579-601) which have demonstrable protective capacityJ. bioRxiv, 2021: 2021.05. 02.442298.
molnova catalog
related products
-
2-Hydroxycaprylic ac...
2-Hydroxycaprylic acid belongs to the class of organic compounds known as medium-chain fatty acids.
-
Haloxyfop
(±)-Haloxyfop is a herbicide.
-
Scutebarbatine A
Scutebarbatine A shows significant antitumor effects on A549 cells in vivo and in vitro via mitochondria-mediated apoptosis by up-regulating expressions of caspase-3 and 9, and down-regulating Bcl-2.
